Prot #NU 12C06: A Phase II Trial of Bevacizumab in Patients with Recurrent Solid Tumor Brain Metastases Who Have Failed Whole Brain Radiation Therapy

Project: Research project

Project Details

StatusFinished
Effective start/end date9/24/1310/30/20

Funding

  • Genentech, Inc ((OE) Prot #NU 12C06)